Metronomic chemotherapy with low-dose cyclophosphamide upregulates the antiangiogenic protein thrombospondin-1, with consequent apoptosis of endothelial cells and suppression of tumor growth [58]. This evidence concerns the gene THBS1 and neoplasm.